Study to Evaluate Multiple Doses in Patients With Nasal Polyposis

NCT02734849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyposis

Interventions

DRUG: AK001 low dose
DRUG: AK001 high dose
DRUG: Placebo

Sponsor

Allakos Inc.